MAFAxitinib Tablet 1 mg, 5 mg
1) For previously treated advanced renal cell carcinoma.
2) Axitinib in combination with avelumab for untreated advanced renal cell carcinoma. Avelumab may be given at a dose of 10 mg/kg up to a maximum of 800 mg, every 2 weeks. Treatment with avelumab should be stopped at 2 years, or earlier if disease progresses.